Equity Capital Markets

Company · CIK 1501796

Aura Biosciences, Inc.

CIK1501796 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
ListedAURA (Nasdaq)
First annual or quarterly report2021-11-24

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-298228
ShelfEffective
 2026-08-112026-08-202
333-278253
ShelfEffective
 2024-03-272026-05-056
333-268105
ShelfEffective
 2022-11-012023-11-076
333-260156
IPOFinal prospectus
 2021-10-082021-11-014

Filings

19
FiledFilingRegistrationAccession
2026-08-20EFFECTDeclared effective 333-2982289999999995-26-002723
2026-08-11S-3Shelf registered 333-2982280001193125-26-344699
2026-05-05424B5Shelf takedown 333-2782530001193125-26-204513
2026-05-04424B5Shelf takedown 333-2782530001193125-26-202458
2025-05-16424B5Shelf takedown 333-2782530001193125-25-121280
2025-05-15424B5Shelf takedown 333-2782530001193125-25-120252
2024-04-05EFFECTDeclared effective 333-2782539999999995-24-000875
2024-03-27S-3Shelf registered 333-2782530001193125-24-078268
2023-11-07424B5Shelf takedown 333-2681050001193125-23-272529
2023-11-06424B5Shelf takedown 333-2681050001193125-23-271382
2022-12-01424B5Shelf takedown 333-2681050001193125-22-296622
2022-11-30424B5Shelf takedown 333-2681050001193125-22-295399
2022-11-07EFFECTDeclared effective 333-2681059999999995-22-003223
2022-11-01S-3Shelf registered 333-2681050001193125-22-275062
2021-11-01424B4Final prospectus 333-2601560001193125-21-314667
2021-10-28EFFECTDeclared effective 333-2601569999999995-21-004081
2021-10-25S-1/AAmendment 333-2601560001193125-21-305934
2021-10-08S-1Registration filed 333-2601560001193125-21-295543
2021-08-10DRSDraft made public 377-053310000950123-21-009996

All filings of this company · CSV